Antitrust Antitrust

EU should learn antitrust lessons for new drug-shortage laws, pharma lobby says

By Lewis Crofts
  • 25 Mar 2021 14:43
  • 25 Mar 2021 14:43
New European Union rules on managing supply shortages shouldn't ignore the lessons learned from antitrust guidance issued at the start of the pandemic to help pharma companies cooperate, a group of generic medicine makers said.
Adrian Van Den Hoven, director general of Medicines for Europe, said primary law, and not

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Lewis Crofts

Editor-In-Chief


Lewis leads MLex's editorial strategy, content direction, quality and development. He has a reputation for breaking stories and providing analysis on complex legal disputes before regulators and courts around the globe. He has also developed MLex's unrivalled coverage of competition policy, litigation, regulation, Brexit and international investigations.

Discover MLex

Stay on top of global regulatory developments

Latest News